Company description

Aptar Pharma is a leading provider of innovative drug delivery systems to pharmaceutical, consumer healthcare and biotech customers worldwide, enabling safe, convenient and compliant medication delivery. Trusted partner of the pharmaceutical community, we provide our customers with the widest portfolio of proven drug delivery devices, components and active packaging solutions backed by decades of regulatory expertise to meet their delivery challenges and help get them to market. Aptar Pharma Services provides a wide array of specialized analytical services from industry leaders Next Breath, Gateway Analytical and Nanopharm, to accelerate and derisk our customers’ drug delivery journey. We have broad therapeutic expertise in Nasal, Pulmonary, Injectables, Eye Care, Dermal delivery routes, among others. With a strong focus on innovation, we are leading the way in developing connected devices to deliver digital medicines. Our global manufacturing footprint of sites in Argentina, China, France, Germany, India, Switzerland, Russia and the U.S. provides security-of-supply and local support to our customers. For more information visit: www.aptar.com/pharma.


Quick facts

Sales markets Western Europe; Eastern Europe; Middle East; Asia; Australia; North America; Africa; Central/South America
Affiliated categories: Closures |Drug Delivery Systems |Medical Devices and Medical Packaging More

Upcoming events

13 oct 2020

CPhI Worldwide 2020

13 - 15 October 2020 Milan, Italy Visit us at stand 6J20 Book a meeting See our Exhibitor Profile   See full Exhibitor List

Recently at

5 nov 2019

CPhI Worldwide 2019

5-7 November 2019 Frankfurt, Germany We were at stand 111D70 See our Exhibitor Profile   See full Exhibitor List

News about Aptar Pharma

FDA approves Unidose device for new nasal seizure rescue treatment

23 Jan 2020

FDA approves Unidose device for new nasal seizure rescue treatment

The single-use, ready-to-use, one-step nasal delivery device can deliver a formulation in an emergency situation quickly and easily.

Read more

6 Nov 2019

Aptar acquires a leader in drug delivery training devices and patient onboarding

Acquisition reflects movement of treatments being administered by patients at home rather than by healthcare providers.

Read more

1 Nov 2019

Aptar Acquires Noble International, a Leader in Drug Delivery Training Devices and Patient Onboarding

AptarGroup, Inc. (NYSE: ATR), a global leader in consumer dispensing, active packaging and drug delivery solutions, announced today that it has acquired Noble International, a leader in drug delivery training devices and patient onboarding.

Read more

23 Oct 2019

FDA approves Activ-Blister packaging solution for oral solid dose HIV prevention medicine

The system protects oral solid drug products with a 3-Phase Activ-Polymer solution that is fully integrated into the blister package.

Read more
Aptar Pharma

Contact information




View all contact information